ArticleScientific reports2025

Two-year follow-up of gait and postural control following initiation of recombinant human tripeptidyl intracerebroventricular enzyme replacement therapy in two atypical CLN2 patients.

Rahul Soangra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.